Mimedx (MDXG) Payables (2010 - 2026)

Mimedx has disclosed Payables across 17 years of filings, most recently posting $8.3 million for Q2 2026.

• In Q2 2026, Payables fell 2.42% year-over-year to $8.3 million; the TTM figure through Jun 2026 stood at $8.3 million (down 2.42% YoY), while the FY2025 annual figure was $14.5 million, up 96.09% from the prior year.
• Payables came in at $8.3 million for Q2 2026 at Mimedx, down from $11.5 million in the prior quarter.
• In the past five years, Payables ranged from a high of $14.5 million in Q4 2025 to a low of $6.9 million in Q3 2024.
• Average Payables over 5 years is $9.0 million, with a median of $8.5 million recorded in 2022.
• Year-over-year, Payables retreated 24.49% in 2024 and soared 96.09% in 2025.
• Over 5 years, Payables stood at $8.5 million in 2022, then climbed by 7.03% to $9.0 million in 2023, then fell by 18.11% to $7.4 million in 2024, then soared by 96.09% to $14.5 million in 2025, then plunged by 42.92% to $8.3 million in 2026.
• Per Business Quant data, the three most recent Payables figures were $8.3 million in Q2 2026, $11.5 million in Q1 2026, and $14.5 million in Q4 2025.